Tuesday, August 9, 2011

BioMarin: Genzyme virus problem won

http://gipnotizer.com/Luxury/Loose-Gemstones/
Genzyme (NASDAQ: GENZ) found a viruxs strain and stopped production of two drugsd atthe Allston, Mass., facility. The strain, Vesivirus apparently does not cause human infection but interrupts the growth of cellxs that are used tomake drugs. Aldurazyme — a treatment for MPS I, a rare and fataol disease caused by an enzymedeficiency — was last filleed at the Genzyme facility in Septemberd 2008, according to BioMarin BMRN). The company has about 10 monthes of vialed inventoryon hand, it said, and uses a secondf fill finish supplier. A third supplier is expecte d to be qualified laterthis year, BioMarin BioMarin makes the bulk material used in Aldurazymd at its Novato facility.
The Food and Drug Administratiomn hadinspected Genzyme’s plant in September and Octoberd and reportedly was concerned aboutg controls to protect against

No comments:

Post a Comment